A study using national healthcare data from the US Department of Veterans Affairs found that individuals who survived the first 30 days of COVID-19 had increased risks of various cardiovascular diseases, including cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure, and thromboembolic disease, even if they were not hospitalized during the acute phase of the infection. These risks increased with the severity of the acute infection. The study compared these risks with those of contemporary and historical control groups and found that the risks were significant across different care settings, including non-hospitalized, hospitalized, and intensive care unit (ICU) admissions. The results showed that the cardiovascular burden was substantial and spanned several categories, with a graded increase in risk according to the severity of the acute infection. The study also found that the risks were consistent across different subgroups, including those without prior cardiovascular disease. The findings suggest that long-term cardiovascular complications of COVID-19 are significant and require attention in post-acute care strategies. The study used a large cohort of 153,760 individuals with COVID-19 and two control groups of 5,637,647 and 5,859,411 individuals, respectively, to estimate the risks and 12-month burdens of cardiovascular outcomes. The results were robust to multiple sensitivity analyses and were consistent with known associations. The study highlights the need for continued efforts to prevent SARS-CoV-2 infections and to address the long-term cardiovascular consequences of the pandemic. The findings have important implications for public health, emphasizing the need for long-term global strategies to manage the impact of the pandemic on cardiovascular health.A study using national healthcare data from the US Department of Veterans Affairs found that individuals who survived the first 30 days of COVID-19 had increased risks of various cardiovascular diseases, including cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure, and thromboembolic disease, even if they were not hospitalized during the acute phase of the infection. These risks increased with the severity of the acute infection. The study compared these risks with those of contemporary and historical control groups and found that the risks were significant across different care settings, including non-hospitalized, hospitalized, and intensive care unit (ICU) admissions. The results showed that the cardiovascular burden was substantial and spanned several categories, with a graded increase in risk according to the severity of the acute infection. The study also found that the risks were consistent across different subgroups, including those without prior cardiovascular disease. The findings suggest that long-term cardiovascular complications of COVID-19 are significant and require attention in post-acute care strategies. The study used a large cohort of 153,760 individuals with COVID-19 and two control groups of 5,637,647 and 5,859,411 individuals, respectively, to estimate the risks and 12-month burdens of cardiovascular outcomes. The results were robust to multiple sensitivity analyses and were consistent with known associations. The study highlights the need for continued efforts to prevent SARS-CoV-2 infections and to address the long-term cardiovascular consequences of the pandemic. The findings have important implications for public health, emphasizing the need for long-term global strategies to manage the impact of the pandemic on cardiovascular health.